Literature DB >> 27812771

The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Rana El Masri1,2,3, Amal Seffouh1,2,3, Hugues Lortat-Jacob1,2,3, Romain R Vivès4,5,6.   

Abstract

The biological properties of Heparan sulfate (HS) polysaccharides essentially rely on their ability to bind and modulate a multitude of protein ligands. These interactions involve internal oligosaccharide sequences defined by their sulfation patterns. Amongst these, the 6-O-sulfation of HS contributes significantly to the polysaccharide structural diversity and is critically involved in the binding of many proteins. HS 6-O-sulfation is catalyzed by 6-O-sulfotransferases (6OSTs) during biosynthesis, and it is further modified by the post-synthetic action of 6-O-endosulfatases (Sulfs), two enzyme families that remain poorly characterized. The aim of the present review is to summarize the contribution of 6-O-sulfates in HS structure/function relationships and to discuss the present knowledge on the complex mechanisms regulating HS 6-O-sulfation.

Entities:  

Keywords:  Biosynthesis; Glycosaminoglycan; Interaction; Structure/function relationships; Sulfatase

Mesh:

Substances:

Year:  2016        PMID: 27812771     DOI: 10.1007/s10719-016-9736-5

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  164 in total

1.  Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.

Authors:  K Kamimura; M Fujise; F Villa; S Izumi; H Habuchi; K Kimata; H Nakato
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

2.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

3.  VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase.

Authors:  Christopher J Robinson; Barbara Mulloy; John T Gallagher; Sally E Stringer
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

4.  HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.

Authors:  Keishi Narita; Julie Staub; Jeremy Chien; Kristy Meyer; Maret Bauer; Andreas Friedl; Sundaram Ramakrishnan; Viji Shridhar
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

5.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

6.  Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.

Authors:  Jenny Presto; Maria Thuveson; Pernilla Carlsson; Marta Busse; Maria Wilén; Inger Eriksson; Marion Kusche-Gullberg; Lena Kjellén
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-12       Impact factor: 11.205

7.  Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.

Authors:  Gregory O Staples; Xiaofeng Shi; Joseph Zaia
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

8.  Differential involvement of the extracellular 6-O-endosulfatases Sulf1 and Sulf2 in brain development and neuronal and behavioural plasticity.

Authors:  Ina Kalus; Benedikt Salmen; Christoph Viebahn; Kurt von Figura; Dietmar Schmitz; Rudi D'Hooge; Thomas Dierks
Journal:  J Cell Mol Med       Date:  2009 Nov-Dec       Impact factor: 5.310

9.  Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology.

Authors:  Gordon C Jayson; Steen U Hansen; Gavin J Miller; Claire L Cole; Graham Rushton; Egle Avizienyte; John M Gardiner
Journal:  Chem Commun (Camb)       Date:  2015-08-03       Impact factor: 6.222

10.  Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification.

Authors:  Yong Li; Changye Sun; Edwin A Yates; Chao Jiang; Mark C Wilkinson; David G Fernig
Journal:  Open Biol       Date:  2016-03       Impact factor: 6.411

View more
  24 in total

1.  Loss of endothelial sulfatase-1 after experimental sepsis attenuates subsequent pulmonary inflammatory responses.

Authors:  Kaori Oshima; Xiaorui Han; Yilan Ouyang; Rana El Masri; Yimu Yang; Sarah M Haeger; Sarah A McMurtry; Trevor C Lane; Pavel Davizon-Castillo; Fuming Zhang; Xinping Yue; Romain R Vivès; Robert J Linhardt; Eric P Schmidt
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-28       Impact factor: 5.464

2.  Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants.

Authors:  Ferdous Anower-E-Khuda; Gagandeep Singh; Yiping Deng; Philip L S M Gordts; Jeffrey D Esko
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

3.  Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblasts.

Authors:  Ruby J Siegel; Anil K Singh; Paul M Panipinto; Farheen S Shaikh; Judy Vinh; Sang U Han; H Mark Kenney; Edward M Schwarz; Cynthia S Crowson; Sadik A Khuder; Basil S Khuder; David A Fox; Salahuddin Ahmed
Journal:  Cell Mol Immunol       Date:  2022-09-07       Impact factor: 22.096

Review 4.  Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes.

Authors:  Maarten Swart; Linda Troeberg
Journal:  J Histochem Cytochem       Date:  2018-09-11       Impact factor: 2.479

5.  High sodium diet converts renal proteoglycans into pro-inflammatory mediators in rats.

Authors:  Ryanne S Hijmans; Pragyi Shrestha; Kwaku A Sarpong; Saleh Yazdani; Rana El Masri; Wilhelmina H A de Jong; Gerjan Navis; Romain R Vivès; Jacob van den Born
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

6.  EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay.

Authors:  Stefano Volpi; Yasuhiro Yamazaki; Patrick M Brauer; Ellen van Rooijen; Atsuko Hayashida; Anne Slavotinek; Hye Sun Kuehn; Maja Di Rocco; Carlo Rivolta; Ileana Bortolomai; Likun Du; Kerstin Felgentreff; Lisa Ott de Bruin; Kazutaka Hayashida; George Freedman; Genni Enza Marcovecchio; Kelly Capuder; Prisni Rath; Nicole Luche; Elliott J Hagedorn; Antonella Buoncompagni; Beryl Royer-Bertrand; Silvia Giliani; Pietro Luigi Poliani; Luisa Imberti; Kerry Dobbs; Fabienne E Poulain; Alberto Martini; John Manis; Robert J Linhardt; Marita Bosticardo; Sergio Damian Rosenzweig; Hane Lee; Jennifer M Puck; Juan Carlos Zúñiga-Pflücker; Leonard Zon; Pyong Woo Park; Andrea Superti-Furga; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2017-02-01       Impact factor: 14.307

Review 7.  Heparan Sulfate Biosynthesis in Zebrafish.

Authors:  Beata Filipek-Górniok; Judith Habicher; Johan Ledin; Lena Kjellén
Journal:  J Histochem Cytochem       Date:  2020-11-20       Impact factor: 2.479

8.  Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.

Authors:  Anett Hudák; Annamária Letoha; László Szilák; Tamás Letoha
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 9.  Heparin Mimetics: Their Therapeutic Potential.

Authors:  Shifaza Mohamed; Deirdre R Coombe
Journal:  Pharmaceuticals (Basel)       Date:  2017-10-02

10.  Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.

Authors:  Victor S Ushakov; Alexandra Y Tsidulko; Gabin de La Bourdonnaye; Galina M Kazanskaya; Alexander M Volkov; Roman S Kiselev; Vyacheslav V Kobozev; Diana V Kostromskaya; Alexey S Gaytan; Alexei L Krivoshapkin; Svetlana V Aidagulova; Elvira V Grigorieva
Journal:  Int J Mol Sci       Date:  2017-11-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.